Alcohol, cardiovascular disease and cancer

Alcohol and Alcoholism

Volumn 48, Issue 5, 2013, Pages 627-628

  Testino, Gianni ^a,b   Patussi, Valentino ^b,c   Scafato, Emanuele ^b,d   Ancarani, Ornella ^a,b   Borro, Paolo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; BREAST CANCER; CARCINOGENICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DRINKING BEHAVIOR; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART PROTECTION; HYPERTENSION; LETTER; NEOPLASM; PRIORITY JOURNAL; CANCER PATIENT; CANCER RISK; HUMAN; NONHUMAN; RISK MANAGEMENT;

CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; HUMANS; POLYPHENOLS; WINE;

ACETALDEHYDE; ACRYLAMIDE; AFLATOXIN; ALCOHOL; ARSENIC; BENZENE; CADMIUM; DIMETHYLNITROSAMINE; FORMALDEHYDE; FURAN; LEAD; OCHRATOXIN; SAFROLE; TELE METHYLHISTAMINE; URETHAN;

EID: 84882972108     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agt064     Document Type: Letter

References (13)

1. Allen NE, Beral V, Casabonne D et al. (2009) Moderate intake and cancer incidence in women. Int Natl Cancer Inst 101:296-30
2. Bagnardi V, Rota M, Botteri E et al. (2013) Light alcohol drinking and cancer: a meta-analysis. Ann Oncol 24:301-8
3. Chiva-Blanch G, Arranz S, Lamuela-Raventos RM et al. (2013) Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol 48:270-77
4. Coltart C, Anderson I, Bahr B et al. (2011) An international consensus for medical leadership on alcohol. Lancet 378:1215
5. Goldberg IJ. (2003) To drink or not to drink? N Engl J Med 348:163-4
6. Higashiyama A, Okamura T, Watanabe M et al. (2013) Alcohol consumption and cardiovascular disease incidence in men with and without hypertension: the Suita study. Hypertens Res 36:58-64
7. IARC (2010) Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum 96:1-1428
8. IARC (2012) A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100E:377-478
9. Lachenmeier DW, Przybylski MC, Rehm J. (2012) Comparative risk assessment of carcinogens in alcoholic beverages using the margin of exposure approach. Int J Cancer 131:E995-1003
10. National Heart Foundation of Australia. Position statement Antioxidant in food, drinks and supplements for cardiovascular health, Canberra, NHF (2010). http://www.heartfoundation.org.au/antioxidants (May 2010, date last accessed)
11. Testino G. (2008) Alcoholic diseases in hepatogastroenterology.Hepatogastroenterol 55:371-7
12. Testino G, Borro P, Ancarani O et al. (2012) Human carcinogenesis and alcohol in hepato-gastroenterology. Eur Rev Med Pharmacol Sci 16:512-8
13. World Health Organization. (2012) Regional Office for Europe.Alcohol in the European Union. Consumption, harm and policy approaches